Suppr超能文献

T 细胞和单核细胞特异性 RNA 测序分析在脓毒症和非脓毒症危重症患者以及癌症患者中的应用。

T Cell- and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer.

机构信息

Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426;

Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.

出版信息

J Immunol. 2019 Oct 1;203(7):1897-1908. doi: 10.4049/jimmunol.1900560. Epub 2019 Sep 4.

Abstract

Sepsis is characterized as life-threatening organ dysfunction caused by a dysregulated host immune response to infection. The purpose of this investigation was to determine the differential effect of sepsis on innate versus adaptive immunity, in humans, by examining RNA expression in specific immune cell subsets, including monocytes/macrophages and CD4 and CD8 T cells. A second aim was to determine immunosuppressive mechanisms operative in sepsis that might be amenable to immunotherapy. Finally, we examined RNA expression in peripheral cells from critically ill nonseptic patients and from cancer patients to compare the unique immune response in these disorders with that occurring in sepsis. Monocytes, CD4 T cells, and CD8 T cells from septic patients, critically ill nonseptic patients, patients with metastatic colon cancer, and healthy controls were analyzed by RNA sequencing. Sepsis induced a marked phenotypic shift toward downregulation of multiple immune response pathways in monocytes suggesting that impaired innate immunity may be fundamental to the immunosuppression that characterizes the disorder. In the sepsis cohort, there was a much more pronounced effect on gene transcription in CD4 T cells than in CD8 T cells. Potential mediators of sepsis-induced immunosuppression included , , and , which were highly upregulated in multiple cell types. Multiple negative costimulatory molecules, including , , , and , were also highly upregulated in sepsis. Although cancer had much more profound effects on gene transcription in CD8 T cells, common immunosuppressive mechanisms were present in all disorders, suggesting that immunoadjuvant therapies that are effective in one disease may also be efficacious in the others.

摘要

败血症的特征是由宿主对感染的免疫反应失调引起的危及生命的器官功能障碍。本研究旨在通过检查特定免疫细胞亚群(包括单核细胞/巨噬细胞和 CD4 和 CD8 T 细胞)中的 RNA 表达,确定败血症对固有免疫与适应性免疫的差异影响。目的二是确定败血症中可能适合免疫治疗的免疫抑制机制。最后,我们检查了来自重症非败血症患者和癌症患者的外周细胞中的 RNA 表达,以比较这些疾病中独特的免疫反应与败血症中发生的反应。通过 RNA 测序分析败血症患者、重症非败血症患者、转移性结肠癌患者和健康对照者的单核细胞、CD4 T 细胞和 CD8 T 细胞。败血症诱导单核细胞中多个免疫反应途径的明显表型转变,表明固有免疫受损可能是该疾病免疫抑制的基础。在败血症组中,CD4 T 细胞的基因转录受到的影响比 CD8 T 细胞更为明显。败血症诱导免疫抑制的潜在介质包括、、和,它们在多种细胞类型中高度上调。多个负性共刺激分子,包括、、和,在败血症中也高度上调。尽管癌症对 CD8 T 细胞的基因转录有更深远的影响,但所有疾病中都存在共同的免疫抑制机制,这表明在一种疾病中有效的免疫佐剂疗法在其他疾病中也可能有效。

相似文献

1
T Cell- and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer.
J Immunol. 2019 Oct 1;203(7):1897-1908. doi: 10.4049/jimmunol.1900560. Epub 2019 Sep 4.
2
Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.
J Immunol. 2001 Jun 1;166(11):6952-63. doi: 10.4049/jimmunol.166.11.6952.
4
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
JCI Insight. 2020 Sep 3;5(17):140329. doi: 10.1172/jci.insight.140329.
5
The Role of Programmed Cell Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) Axis in Sepsis-Induced Apoptosis.
Medicina (Kaunas). 2024 Jul 19;60(7):1174. doi: 10.3390/medicina60071174.
6
CD4 and CD8 T Cell Memory Interactions Alter Innate Immunity and Organ Injury in the CLP Sepsis Model.
Front Immunol. 2020 Nov 20;11:563402. doi: 10.3389/fimmu.2020.563402. eCollection 2020.
8
Sepsis-induced long-term immune paralysis--results of a descriptive, explorative study.
Crit Care. 2016 Feb 29;20:93. doi: 10.1186/s13054-016-1233-5.
10
Lymphocyte expression of EZH2 is associated with mortality and secondary infectious complications in sepsis.
Int Immunopharmacol. 2020 Dec;89(Pt B):107042. doi: 10.1016/j.intimp.2020.107042. Epub 2020 Oct 14.

引用本文的文献

3
Subtyping colorectal cancer based on septic shock-associated genes: prognosis and immune characteristics.
Front Genet. 2024 Nov 15;15:1468424. doi: 10.3389/fgene.2024.1468424. eCollection 2024.
5
Plac8-ERK pathway modulation of monocyte function in sepsis.
Cell Death Discov. 2024 Jul 3;10(1):308. doi: 10.1038/s41420-024-02012-4.
6
TEMPORAL CHANGES IN INNATE AND ADAPTIVE IMMUNITY DURING SEPSIS AS DETERMINED BY ELISPOT.
Shock. 2024 Aug 1;62(2):255-264. doi: 10.1097/SHK.0000000000002377. Epub 2024 May 3.
7
Immune dysregulation in sepsis: experiences, lessons and perspectives.
Cell Death Discov. 2023 Dec 19;9(1):465. doi: 10.1038/s41420-023-01766-7.
9
Multi-Omics Endotypes in ICU Sepsis-Induced Immunosuppression.
Microorganisms. 2023 Apr 25;11(5):1119. doi: 10.3390/microorganisms11051119.
10
Cancer and sepsis.
Clin Sci (Lond). 2023 Jun 14;137(11):881-893. doi: 10.1042/CS20220713.

本文引用的文献

1
Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis.
J Clin Invest. 2019 Apr 8;129(5):2014-2028. doi: 10.1172/JCI125917.
3
Persistent inflammation and anemia among critically ill septic patients.
J Trauma Acute Care Surg. 2019 Feb;86(2):260-267. doi: 10.1097/TA.0000000000002147.
4
Single-Cell RNA Sequencing of Blood and Ileal T Cells From Patients With Crohn's Disease Reveals Tissue-Specific Characteristics and Drug Targets.
Gastroenterology. 2019 Feb;156(3):812-815.e22. doi: 10.1053/j.gastro.2018.10.046. Epub 2018 Nov 2.
5
Recruitment of CCR2 tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer.
Oncoimmunology. 2018 Aug 1;7(9):e1470729. doi: 10.1080/2162402X.2018.1470729. eCollection 2018.
6
Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration.
PLoS One. 2018 Jun 26;13(6):e0199497. doi: 10.1371/journal.pone.0199497. eCollection 2018.
7
Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery.
Surgery. 2018 Aug;164(2):178-184. doi: 10.1016/j.surg.2018.04.011. Epub 2018 May 26.
8
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.
JCI Insight. 2018 Mar 8;3(5):98960. doi: 10.1172/jci.insight.98960.
9
Management of Sepsis-Induced Immunosuppression.
Crit Care Clin. 2018 Jan;34(1):97-106. doi: 10.1016/j.ccc.2017.08.007. Epub 2017 Oct 6.
10
Understanding Immunosuppression after Sepsis.
Immunity. 2017 Jul 18;47(1):3-5. doi: 10.1016/j.immuni.2017.07.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验